Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Convertible Note and Placement October 17, 2025 Completes Two Pools Gold acquisition October 17, 2025 Strategic Entry into Australian Gas Infrastructure Sector October 17, 2025